121 related articles for article (PubMed ID: 19022677)
1. Acidic heterocycles as novel hydrophilic pharmacophore of androgen receptor ligands with a carborane core structure.
Fujii S; Ohta K; Goto T; Kagechika H; Endo Y
Bioorg Med Chem; 2009 Jan; 17(1):344-50. PubMed ID: 19022677
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.
Ohta K; Goto T; Fujii S; Kawahata M; Oda A; Ohta S; Yamaguchi K; Hirono S; Endo Y
Bioorg Med Chem; 2011 Jun; 19(11):3540-8. PubMed ID: 21536446
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
Goto T; Ohta K; Fujii S; Ohta S; Endo Y
J Med Chem; 2010 Jul; 53(13):4917-26. PubMed ID: 20521823
[TBL] [Abstract][Full Text] [Related]
4. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
5. A new class of androgen receptor antagonists bearing carborane in place of a steroidal skeleton.
Fujii S; Hashimoto Y; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem Lett; 2005 Jan; 15(1):227-30. PubMed ID: 15582444
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes.
Goto T; Ohta K; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2005 Dec; 13(23):6414-24. PubMed ID: 16099660
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-cancer activity of dinuclear platinum(II) complexes containing bis(thioalkyl)dicarba-closo-dodecaborane(12) ligands.
Woodhouse SL; Ziolkowski EJ; Rendina LM
Dalton Trans; 2005 Sep; (17):2827-9. PubMed ID: 16094469
[TBL] [Abstract][Full Text] [Related]
9. Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Iijima T; Yamakoshi Y; Yamaguchi M; Fukasawa H; Shudo K
J Med Chem; 1999 May; 42(9):1501-4. PubMed ID: 10229620
[No Abstract] [Full Text] [Related]
10. Novel androgen receptor full antagonists: Design, synthesis, and a docking study of glycerol and aminoglycerol derivatives that contain p-carborane cages.
Kaise A; Ohta K; Fujii S; Oda A; Goto T; Endo Y
Bioorg Med Chem; 2018 Jul; 26(13):3805-3811. PubMed ID: 29903411
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
Yoo J; Do Y
Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
[TBL] [Abstract][Full Text] [Related]
12. Novel vitamin D receptor ligands bearing a spherical hydrophobic core structure--comparison of bicyclic hydrocarbon derivatives with boron cluster derivatives.
Wongmayura A; Fujii S; Ito S; Kano A; Taoda Y; Kawachi E; Kagechika H; Tanatani A
Bioorg Med Chem Lett; 2012 Feb; 22(4):1756-60. PubMed ID: 22285943
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide.
Parent EE; Jenks C; Sharp T; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 2006 Aug; 33(6):705-13. PubMed ID: 16934689
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.
Van Dort ME; Jung YW
Bioorg Med Chem Lett; 2004 Nov; 14(21):5285-8. PubMed ID: 15454212
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
[TBL] [Abstract][Full Text] [Related]
16. Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors: Dual activities and metabolic activation.
Hosoda S; Tanatani A; Wakabayashi K; Makishima M; Imai K; Miyachi H; Nagasawa K; Hashimoto Y
Bioorg Med Chem; 2006 Aug; 14(16):5489-502. PubMed ID: 16698269
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations.
Bisson WH; Abagyan R; Cavasotto CN
J Mol Graph Model; 2008 Nov; 27(4):452-8. PubMed ID: 18805032
[TBL] [Abstract][Full Text] [Related]
18. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.
Marhefka CA; Moore BM; Bishop TC; Kirkovsky L; Mukherjee A; Dalton JT; Miller DD
J Med Chem; 2001 May; 44(11):1729-40. PubMed ID: 11356108
[TBL] [Abstract][Full Text] [Related]
19. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
Zhang X; Li X; Allan GF; Musto A; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2006 Jun; 16(12):3233-7. PubMed ID: 16603353
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of novel peptide mimetics as melanocortin receptor agonists.
Liu XW; Ma J; Colson AO; Doersen DC; Ebetino FH
Bioorg Med Chem Lett; 2008 Feb; 18(3):1223-8. PubMed ID: 18078748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
